Accelerated development of lofexidine for neonatal opioid withdrawal syndrome
Ended Project Grant Awarded Last action
- Award ID
- R01DA047690
- Recipient
-
MDD US Operations, LLC UEI NKGSYBV5UGN1
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,254,694
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date
- Place of performance
- Kentucky, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$272,653 | |
| Amendment | -$272,653 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $800,000 | |
| Amendment | $0 | |
| Amendment | $2,330,000 | |
| Amendment | $0 | |
| Original award | $670,000 |
Quick answers
Who received award R01DA047690?
R01DA047690 was awarded to MDD US Operations, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2018.
How much is award R01DA047690 worth?
$3,254,694 has been obligated on R01DA047690.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award